Digital handshake with futuristic technology overlay.

Investors

PapEasy represents an opportunity to participate in the modernization of cervical cancer screening through differentiated medical device innovation, a comprehensive program model, digital health capabilities, and long-term data and AI potential in women’s health.

The platform is designed to address one of the most significant gaps in global healthcare—access to effective, acceptable, and scalable cervical cancer screening solutions.

A Large and Urgent Global Need

Cervical cancer remains one of the most preventable forms of cancer, yet it continues to affect hundreds of thousands of women each year—particularly in regions where screening access is limited or inconsistent.

This represents a substantial global health challenge, as well as an opportunity to improve outcomes through more modern and accessible screening approaches.

Addressing an Unmet Need

Traditional screening methods have not evolved at the pace needed to meet current patient and system demands. Barriers related to discomfort, accessibility, provider dependence, and fragmented workflows continue to limit participation in screening programs.

PapEasy is focused on addressing these gaps through a more women-centered and flexible approach to screening.

Platform and Program Model

PapEasy is being developed as more than a single device—it is a comprehensive platform designed to support screening across multiple care settings, including clinical environments, mobile programs, and centralized lab-supported workflows.

This approach enables scalable program deployment and broader reach across diverse healthcare systems.

Innovation, IP, and Differentiation

PapEasy’s strategy includes ongoing development of intellectual property and trademark assets across key markets, supporting long-term differentiation and competitive positioning in cervical cancer screening innovation.

The platform combines device innovation with digital capabilities to create a differentiated approach to screening modernization.

Digital Health and AI Potential

PapEasy is building a foundation for future digital health integration, including data capture, workflow optimization, and potential AI-enabled insights.

Over time, this creates opportunities for scalable reporting, telemedicine integration, and long-term data-driven value in women’s health.

Scalable Commercialization Pathways

PapEasy is designed to support multiple commercialization pathways, including partnerships with healthcare providers, laboratories, public health organizations, and global health programs.

This flexibility enables deployment across a range of markets and care environments, supporting long-term growth and impact.

Connect With Us

PapEasy welcomes conversations with investors who are interested in supporting the advancement of cervical cancer screening and women’s health innovation.

If you would like to learn more about investment opportunities, please contact our team to begin the conversation.

"*" indicates required fields